Xueling Lu

Xueling Lu

Auto-generated profile, based on publicly available information

Xueling Lu

Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Laboratory of Environmental Medicine and Developmental Toxicology, Shantou University Medical College, Guangdong, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2025 in Diabetologia
Verified
Journal Article
Open access
PDF file
LSLucy Sinke
Lucy Sinke
TDThomas Delerue
Thomas Delerue
RWRory Wilson
Rory Wilson
XLXueling Lu
Xueling Lu
YXYujing Xia
Yujing Xia
BHBastiaan T. Heijmans
Bastiaan T. Heijmans
Aims/hypothesis: Despite playing critical roles in the pathophysiology of type 2 diabetes and other metabolic disorders, the molecular mechanisms underlying circulating adipokine levels remain poorly understood. By identifying genomic regions involved in the regulation of adipokine levels and adipokine-mediated disease risk, we can improve our understanding of type 2 diabetes pathogenesis and inter-individual differences in metabolic risk. Methods: We conducted an epigenome-wide meta-analysis of associations between serum adiponectin ( n =2791) and leptin ( n =3661) and leukocyte DNA methylation at over 400,000 CpG sites across five European cohorts. The resulting methylation signatures were followed up using functional genomics, integrative analyses and causal inference methods. Results: Our findings revealed robust associations with adiponectin at 73 CpGs and leptin at 211 CpGs. Many of the identified sites were also associated with risk factors for the metabolic syndrome and located in enhancers close to relevant transcription factor binding sites. Integrative analyses additionally linked 35 of the adiponectin-associated CpGs to the expression of 46 genes, and 100 of the leptin-associated CpGs to the expression of 151 genes, with implicated genes enriched for lipid transport (e.g. ABCG1 ), metabolism (e.g. CPT1A ) and biosynthesis (e.g. DHCR24 ). Bidirectional two-sample Mendelian randomisation further identified two specific CpG sites as plausible drivers of both adiponectin levels and metabolic health: one annotated to ADIPOQ , the gene encoding adiponectin; and another linked to the expression of SREBF1 , an established modifier of type 2 diabetes risk known to exert its effects via adiponectin. Conclusions/interpretation: Taken together, these large-scale and integrative analyses uncovered links between adipokines and widespread, yet functionally specific, differences in regulation of genes with a central role in type 2 diabetes and its risk factors. Graphical

26 October 2025 in European Neuropsychopharmacology
Verified
Journal Article
Open access
MMMandy Meijer
Mandy Meijer
JSJonathan Sebat
Jonathan Sebat
DCDoretta Caramaschi
Doretta Caramaschi
SCShaunna L. Clark
Shaunna L. Clark
MCMarta Cosin-Tomas
Marta Cosin-Tomas
EOEdwin J.C.G. van Den Oord
Edwin J.C.G. van Den Oord
Studying DNA methylation (DNAm) can provide insights into gene-regulatory mechanisms underlying attention-deficit/hyperactivity disorder (ADHD). While most DNAm studies were performed in bulk tissue, this study used statistical deconvolution to identify cell type-specific DNAm profiles, from five major blood cell types, associated with childhood ADHD symptoms. We performed meta-analyses of methylome-wide association studies (MWAS) for ADHD symptoms (agerange=4-16 years) in peripheral blood collected during childhood and in cord blood. The investigated cohorts included seven array-based methylation datasets assaying up to 450 K CpGs from the Pregnancy And Childhood Epigenetics Consortium (N=2 934 peripheral blood; N=2 546 cord blood) and a sequencing-based methylation dataset assaying nearly all 28 million CpGs in blood from the Great Smoky Mountain Study (GSMS; N=583). The meta-analyses resulted in methylome-wide significant (FDR<0.05) ADHD associations in CD8T cells (RPL31P11 and KCNJ5) for peripheral blood, and, in cord blood, in monocytes (PDE6B), CD8T cells (KCNA3 and HAND2), and NK cells (KIFC1). Notably, several significant sites detected in peripheral blood (RPL31P11 and KCNJ5) were also detected in cord blood. Furthermore, extended MWAS of all sites available for GSMS detected 69 and 17 additional CpGs in monocytes and granulocytes, respectively. In this first cell type-specific MWAS for ADHD, we identified DNAm associations for ADHD symptoms; some associations were seen in both peripheral blood and cord blood, suggesting potential susceptibility markers for increased ADHD risk. These findings show that cell type-specific analyses and sequencing-based approaches can increase insights into the epigenetic patterns associated with ADHD symptoms in childhood.